| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
|
Nat Med
|
2002
|
23.42
|
|
2
|
Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors.
|
Am J Surg Pathol
|
2002
|
2.29
|
|
3
|
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
|
Oncogene
|
2002
|
2.16
|
|
4
|
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.
|
Appl Immunohistochem Mol Morphol
|
2007
|
2.15
|
|
5
|
HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.
|
Mayo Clin Proc
|
2002
|
1.59
|
|
6
|
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.
|
Endocrinology
|
2002
|
1.45
|
|
7
|
Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
|
Clin Cancer Res
|
2002
|
1.33
|
|
8
|
Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
|
Clin Cancer Res
|
2005
|
1.26
|
|
9
|
Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
|
Breast Cancer Res Treat
|
2002
|
1.26
|
|
10
|
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study.
|
Arch Pathol Lab Med
|
2006
|
1.19
|
|
11
|
Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey.
|
Arch Pathol Lab Med
|
2006
|
1.04
|
|
12
|
Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.
|
Breast Cancer Res Treat
|
2004
|
0.96
|
|
13
|
Metallographic in situ hybridization.
|
Hum Pathol
|
2007
|
0.88
|
|
14
|
Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
|
Cancer
|
2003
|
0.84
|
|
15
|
Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study.
|
Appl Immunohistochem Mol Morphol
|
2006
|
0.82
|
|
16
|
Endometrial cancer: can nodal status be predicted with curettage?
|
Gynecol Oncol
|
2005
|
0.78
|
|
17
|
Molecular and histopathologic predictors of distant failure in endometrial cancer.
|
Cancer Detect Prev
|
2003
|
0.77
|
|
18
|
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy.
|
Gynecol Oncol
|
2003
|
0.77
|
|
19
|
Genotyping of phenotypically defined cells in neoplasia: enhanced immunoFISH via tyramide signal amplification (TSA) segregates immunophenotypically-defined cell populations for gated genotyping.
|
J Mol Histol
|
2007
|
0.77
|
|
20
|
A new rabbit monoclonal antibody (4B5) for the immuno-histochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.
|
Appl Immunohistochem Mol Morphol
|
2008
|
0.77
|